• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki-67指数在婴儿原发性颅内肿瘤中的预后价值

Prognostic value of Ki-67 index in primary intracranial tumors of infants.

作者信息

Tahta Alican, Akalan Nejat

机构信息

Istanbul Medipol University, School of Medicine, Department of Neurosurgery, TEM Goztepe exit, Bagcila, Istanbul, Turkey.

出版信息

Childs Nerv Syst. 2023 Feb;39(2):369-377. doi: 10.1007/s00381-022-05822-y. Epub 2023 Jan 6.

DOI:10.1007/s00381-022-05822-y
PMID:36607388
Abstract

OBJECTIVE

Primary intracranial tumors are rare tumors in infants. They differ from those found in other pediatric age groups in terms of clinical presentation, histopathological diagnosis, adjuvant therapies, and outcome. Ki-67 index has also shown promising results as a prognostic factor in different types of intracranial tumors in children and adults. However, the importance and the best cutoff point of Ki-67 index in primary intracranial tumors of infants remains unclear. We aimed to analyze prognostic value of Ki-67 index in primary intracranial tumors of infants.

METHODS

This study retrospectively reviewed the records of 28 infants undergoing surgical resection for primary intracranial tumors between April 2016 and March 2021. We analyzed clinical characteristics, tumor location, extent of resection, histopathological diagnosis, Ki-67 index, and overall survival (OS). To define the most relevant cutoff value for Ki-67 index, "Cutoff Finder" was used.

RESULTS

The median age at diagnosis was 188 days for all patients. Fifteen of the patients were boys and 13 were girls. Tumors were located supratentorial in 13 patients and infratentorial in 15 patients. Gross total resection was performed in 7 of 13 supratentorial tumors and 9 of 15 infratentorial tumors. The mean Ki-67 index of the supratentorial tumors was 49.6%, the median was 55%; for infratentorial tumors, the mean was 49.9%, and the median was 70%. Tumor grade (p = 0.019) and Ki-67 index (p = 0.003) were found as significant predictors of OS in log-rank testing for Kaplan-Meier survival analysis. Univariate cox regression analysis identified high Ki-67 index as prognostic factor for worse OS, with hazard ratio of 8.852 (95% CI 1.95-64.80; p = 0.0108). High Ki-67 index was found as independent prognostic factor for worse OS in multivariate cox regression analysis (HR 7.036; 95% CI 1.229-65.82; p = 0.0457).

CONCLUSION

High-grade and high Ki-67 index were associated with worse outcome. Ki-67 index did show a distinct prognostic value for OS within our cohort at a cutoff value of 72.5%.

摘要

目的

原发性颅内肿瘤在婴儿中是罕见肿瘤。它们在临床表现、组织病理学诊断、辅助治疗及预后方面与其他儿童年龄组中发现的肿瘤有所不同。Ki-67指数作为儿童和成人不同类型颅内肿瘤的预后因素也显示出有前景的结果。然而,Ki-67指数在婴儿原发性颅内肿瘤中的重要性及最佳临界值仍不清楚。我们旨在分析Ki-67指数在婴儿原发性颅内肿瘤中的预后价值。

方法

本研究回顾性分析了2016年4月至2021年3月期间28例接受原发性颅内肿瘤手术切除的婴儿的记录。我们分析了临床特征、肿瘤位置、切除范围、组织病理学诊断、Ki-67指数及总生存期(OS)。为确定Ki-67指数最相关的临界值,使用了“临界值查找器”。

结果

所有患者诊断时的中位年龄为188天。其中15例为男孩,13例为女孩。13例患者肿瘤位于幕上,15例位于幕下。13例幕上肿瘤中的7例及15例幕下肿瘤中的9例进行了全切除。幕上肿瘤的平均Ki-67指数为49.6%,中位数为55%;幕下肿瘤的平均指数为49.9%,中位数为70%。在Kaplan-Meier生存分析的对数秩检验中,肿瘤分级(p = 0.019)和Ki-67指数(p = 0.003)被发现是OS的显著预测因素。单因素Cox回归分析确定高Ki-67指数是OS较差的预后因素,风险比为8.852(95%CI 1.95 - 64.80;p = 0.0108)。在多因素Cox回归分析中,高Ki-67指数被发现是OS较差的独立预后因素(HR 7.036;95%CI 1.229 - 65.82;p = 0.0457)。

结论

高级别及高Ki-67指数与较差的预后相关。在我们的队列中,Ki-67指数在临界值为72.5%时确实对OS显示出明显的预后价值。

相似文献

1
Prognostic value of Ki-67 index in primary intracranial tumors of infants.Ki-67指数在婴儿原发性颅内肿瘤中的预后价值
Childs Nerv Syst. 2023 Feb;39(2):369-377. doi: 10.1007/s00381-022-05822-y. Epub 2023 Jan 6.
2
Prognostic factors in intracranial ependymomas in children.儿童颅内室管膜瘤的预后因素
J Neurosurg. 2000 Oct;93(4):605-13. doi: 10.3171/jns.2000.93.4.0605.
3
Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.幕上脑室外室管膜瘤:一项关注长期预后及预后因素的回顾性研究。
Clin Neurol Neurosurg. 2018 Feb;165:1-6. doi: 10.1016/j.clineuro.2017.12.013. Epub 2017 Dec 13.
4
Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.小儿幕下室管膜瘤:间变组织学的预后意义。
J Neurooncol. 2012 Feb;106(3):619-26. doi: 10.1007/s11060-011-0699-x. Epub 2011 Aug 24.
5
Prognosis by tumor location in adults with intracranial ependymomas.颅内室管膜瘤成人患者肿瘤位置的预后情况
J Clin Neurosci. 2014 Dec;21(12):2096-101. doi: 10.1016/j.jocn.2014.05.011. Epub 2014 Jul 15.
6
Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.幕上脑半球室管膜瘤:109 例成人患者的生存分析及预后因素。
J Neurosurg. 2016 Aug;125(2):410-8. doi: 10.3171/2015.7.JNS151187. Epub 2016 Jan 8.
7
Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.Ki-67 在原发性切除术后肾上腺皮质癌中的预后作用:一项回顾性单机构研究。
Adv Ther. 2019 Oct;36(10):2756-2768. doi: 10.1007/s12325-019-01050-0. Epub 2019 Aug 30.
8
Survival and Prognostic Factors of Adult Intracranial Ependymoma: A Single-institutional Analysis of 236 Patients.成人颅内室管膜瘤的生存和预后因素:单机构 236 例分析。
Am J Surg Pathol. 2021 Jul 1;45(7):979-987. doi: 10.1097/PAS.0000000000001669.
9
A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.小儿颅内室管膜瘤治疗结果的系统评价。
J Neurosurg Pediatr. 2013 Jun;11(6):673-81. doi: 10.3171/2013.2.PEDS12345. Epub 2013 Mar 29.
10
[Clinical presentation of supratentorial and infratentorial intracranial tumors in pediatric patients].[小儿幕上和幕下颅内肿瘤的临床表现]
Gac Med Mex. 2016 Mar-Apr;152(2):158-62.

本文引用的文献

1
Pediatric brain tumors: a bibliometric analysis.小儿脑肿瘤:文献计量分析。
Childs Nerv Syst. 2022 Jun;38(6):1095-1104. doi: 10.1007/s00381-022-05506-7. Epub 2022 Mar 19.
2
Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups.基于人群的中枢神经系统肿瘤在先天性和婴儿期的诊断、治疗和生存分析。
J Neurooncol. 2022 Apr;157(2):333-344. doi: 10.1007/s11060-022-03967-z. Epub 2022 Feb 17.
3
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.
肿瘤细胞 IDO 增强免疫抑制作用并降低胶质母细胞瘤患者的存活率,与色氨酸代谢无关。
Clin Cancer Res. 2021 Dec 1;27(23):6514-6528. doi: 10.1158/1078-0432.CCR-21-1392. Epub 2021 Sep 3.
4
Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.IDH 野生型胶质母细胞瘤中 Ki-67 指数过表达是否预示无进展生存期更短?一项临床和分子分析研究。
Clin Neurol Neurosurg. 2020 Nov;198:106126. doi: 10.1016/j.clineuro.2020.106126. Epub 2020 Aug 3.
5
Congenital tumors of the central nervous system: an institutional review of 64 cases with emphasis on tumors with unique histologic and molecular characteristics.中枢神经系统先天性肿瘤:64 例机构审查,重点介绍具有独特组织学和分子特征的肿瘤。
Brain Pathol. 2021 Jan;31(1):45-60. doi: 10.1111/bpa.12885. Epub 2020 Aug 4.
6
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer.Ki-67 在三阴性乳腺癌中的预后和预测潜力。
Sci Rep. 2020 Jan 14;10(1):225. doi: 10.1038/s41598-019-57094-3.
7
Perioperative Factors Affecting Neurologic Outcome in Infants Undergoing Surgery for Intracranial Lesion: A Retrospective Study.围手术期因素对颅内病变手术婴儿神经结局的影响:一项回顾性研究。
World Neurosurg. 2019 Oct;130:e702-e708. doi: 10.1016/j.wneu.2019.06.196. Epub 2019 Jul 4.
8
Correlation of Ki-67 Index with Volumetric Segmentation and its Value as a Prognostic Marker in Glioblastoma.Ki-67 指数与容积分割的相关性及其作为胶质母细胞瘤预后标志物的价值。
World Neurosurg. 2019 May;125:e1093-e1103. doi: 10.1016/j.wneu.2019.02.006. Epub 2019 Feb 18.
9
Perioperative risk calculator for distal gastrectomy predicts overall survival in patients with gastric cancer.远端胃癌切除术围手术期风险计算器预测胃癌患者的总生存率。
Gastric Cancer. 2019 May;22(3):624-631. doi: 10.1007/s10120-018-0896-9. Epub 2018 Nov 26.
10
Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.Ki-67 指数在考虑分子亚组后对成人髓母细胞瘤的预后价值:回顾性临床和分子分析。
J Neurooncol. 2018 Sep;139(2):333-340. doi: 10.1007/s11060-018-2865-x. Epub 2018 Apr 23.